Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-20
2009-10-20
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S266300, C544S284000, C544S285000, C544S286000
Reexamination Certificate
active
07605165
ABSTRACT:
The present invention relates to the following phenylalanine derivatives or analogues thereof having an antagonistic activity to α4 integrin and therapeutic agents for various diseases concerning α4 integrin.
REFERENCES:
patent: 6610710 (2003-08-01), Tanaka et al.
patent: 7153963 (2006-12-01), Makino et al.
patent: 7160874 (2007-01-01), Tanaka et al.
patent: 2005/0222141 (2005-10-01), Sagi et al.
patent: 2006/0009476 (2006-01-01), Kataoka et al.
patent: 2006/0204572 (2006-09-01), Higuchi et al.
patent: 2006/0223836 (2006-10-01), Makino et al.
patent: 2007/0018172 (2007-01-01), Takahashi et al.
patent: 1 233 013 (2002-08-01), None
patent: WO 93/13798 (1993-07-01), None
patent: WO 93/15764 (1993-08-01), None
patent: WO 94/15958 (1994-07-01), None
patent: WO 94/16094 (1994-07-01), None
patent: WO 95/15790 (1995-06-01), None
patent: WO 95/15973 (1995-06-01), None
patent: WO 96/00581 (1996-01-01), None
patent: WO 96/06108 (1996-02-01), None
patent: WO 99/06437 (1999-02-01), None
patent: WO 99/10312 (1999-03-01), None
patent: WO 99/10313 (1999-03-01), None
patent: WO 99/36393 (1999-07-01), None
patent: WO 99/37618 (1999-07-01), None
patent: WO 99/43642 (1999-09-01), None
patent: WO 01/36376 (2001-05-01), None
patent: WO 02/16329 (2002-02-01), None
Gasperini, C. et. al., “Emerging oral drugs for multiple sclerosis”. Expert Opinion Emerging Drugs, (2008), vol. 13, No. 3, pp. 465-477.
U.S. Appl. No. 10/150,067, filed May 20, 2002, Tanaka, et al.
U.S. Appl. No. 10/252,003, filed Sep. 23, 2002, Izawa, et al.
U.S. Appl. No. 10/300,856, filed Nov. 21, 2002, Makino, et al.
U.S. Appl. No. 10/402,006, filed Mar. 31, 2003, Suzuki, et al.
U.S. Appl. No. 10/763,237, filed Jan. 26, 2004, Chiba, et al.
U.S. Appl. No. 10/866,260, filed Jun. 14, 2004, Okuzumi, et al.
U.S. Appl. No. 11/767,969, filed Jun. 25, 2007, Okuzumi, et al.
U.S. Appl. No. 11/430,284, filed May 9, 2006, Makino, et al.
U.S. Appl. No. 11/018,226, filed Dec. 22, 2004, Sagi, et al.
U.S. Appl. No. 11/963,144, filed Dec. 21, 2007, Sagi, et al.
Chiba Akira
Izawa Hiroyuki
Murata Masahiro
Okuzumi Tatsuya
Ono Miho
Ajinomoto Co. Inc.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Truong Tamthom N
Wilson James O
LandOfFree
Phenylalanine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalanine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalanine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4064286